Evidence map›Paper›PMID 24204272›Full record

ArticlePLoS pathogens2013

Viral interference with DNA repair by targeting of the single-stranded DNA binding protein RPA.

Pubali Banerjee, Rowena DeJesus, Ole Gjoerup, Brian S Schaffhausen

Abstract read
In one paragraph

Article in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8Therapeutic advances in vaccines and immunotherapy · 2020
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. The "histone mimicry" by pathogens.Cold Spring Harbor symposia on quantitative biology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pubali BanerjeeDepartment of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, United States of America ; Program in Molecular Microbiology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
Rowena DeJesus
Ole Gjoerup
Brian S Schaffhausen

Funding

PRODUCTS OF THE TRANSFORMING GENES OF POLYOMAVIRUSR01CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1985 to 2015
$6.0M
Role of Bub1 in SV40 large T antigen mediated transformation and replicationR01AI078926 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GJOERUP, OLE · 2008 to 2011
$1.5M
PRODUCTS OF THE TRANSFORMING GENES OF POLYOMA VIRUSR37CA034722 · NCI · TUFTS UNIVERSITY BOSTON · PI SCHAFFHAUSEN, BRIAN S · 1991 to 1998
–
NCI NIH HHS CA34722NCI NIH HHS R01 CA034722NIAID NIH HHS AI078926NIAID NIH HHS R01 AI078926PHS HHS P050661
6 · The paper itself

Abstract

Correct repair of damaged DNA is critical for genomic integrity. Deficiencies in DNA repair are linked with human cancer. Here we report a novel mechanism by which a virus manipulates DNA damage responses. Infection with murine polyomavirus sensitizes cells to DNA damage by UV and etoposide. Polyomavirus large T antigen (LT) alone is sufficient to sensitize cells 100 fold to UV and other kinds of DNA damage. This results in activated stress responses and apoptosis. Genetic analysis shows that LT sensitizes via the binding of its origin-binding domain (OBD) to the single-stranded DNA binding protein replication protein A (RPA). Overexpression of RPA protects cells expressing OBD from damage, and knockdown of RPA mimics the LT phenotype. LT prevents recruitment of RPA to nuclear foci after DNA damage. This leads to failure to recruit repair proteins such as Rad51 or Rad9, explaining why LT prevents repair of double strand DNA breaks by homologous recombination. A targeted intervention directed at RPA based on this viral mechanism could be useful in circumventing the resistance of cancer cells to therapy.

Indexed as

DNA RepairAnimalsAntigens, Viral, TumorCell Cycle ProteinsDNA DamageDNA, Single-StrandedHumansMiceNIH 3T3 CellsPolyomavirusRad51 RecombinaseReplication Protein AAntigens, Viral, TumorCell Cycle ProteinsDNA, Single-StrandedRAD51 protein, humanRad51 protein, mouseRad51 Recombinaserad9 proteinReplication Protein ARPA1 protein, humanRpa1 protein, mouse

Identifiers

PMID24204272
PMCPMC3812037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.